CompletedNCT07178691
Official study titleA Precision Medicine Approach to the Prevention of Depression in Patients With Atrial Fibrillation - HOPE-AF
This study has finished and is no longer accepting participants.
Multiple locations, including AalborgDepression, AnxietyInterventional studyAges 18+
- Countries
- Denmark
- Sponsor
- University of Southern Denmark
CompletedNCT07100548
Official study titleMental Health in the Digital Age: A Qualitative Study of Youth Responses to Depression Education Delivered on Social Media
This study has finished and is no longer accepting participants.
In MunichDepressionObservational studyAges 13–18
- Countries
- Germany
- Sponsor
- Ludwig-Maximilians - University of Munich
Active Not RecruitingNCT07102017
Official study titleThe Impact of Socially Supportive Robotic Intervention on Loneliness, Depression, Self-agency and Well-being in Long-term Care Residents: A Three-Arm Randomized Controlled Trial
This study is no longer accepting new participants.
In ShanghaiDepressionDevice studyAges 65+
- Countries
- China
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Active Not RecruitingNCT06775379
What is this study about?Researchers are comparing Azetukalner and placebo to find out how the approaches affect depression symptoms in people with depression.
This study is no longer accepting new participants.
Multiple locations, including PhoenixDepressionMedication studyAges 18–74
- Countries
- United States
- Sponsor
- Xenon Pharmaceuticals Inc.
Active Not RecruitingNCT07076407
What is this study about?Researchers are comparing Azetukalner and placebo to find out how the approaches affect depression symptoms in people with depression.
This study is no longer accepting new participants.
Multiple locations, including DothanDepressionMedication studyAges 18–74
- Countries
- United States, Finland, Germany, + 4 others
- Sponsor
- Xenon Pharmaceuticals Inc.
CompletedNCT01941043
Official study titleA Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamDepression, SuicidalityMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Avalo Therapeutics, Inc.
CompletedNCT02476058
What is this study about?Researchers compared JNJ-42847922, Diphenhydramine and placebo, tracking side effects to assess safety and tolerability in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including AalstDepressionMedication studyAges 18–64
- Countries
- Belgium, Germany, Netherlands
- Sponsor
- Janssen-Cilag International NV
CompletedNCT00095758
Official study titleA Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Beverly HillsDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00105196
Official study titleA Study of Aripiprazole in Patients With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT04103892
What is this study about?Researchers compared CLE-100 and placebo to find out how the approaches affected depression symptoms in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Clexio Biosciences Ltd.
CompletedNCT06254612
What is this study about?Researchers compared SP-624 and placebo to find out how the approaches affected depression symptoms in adults with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Sirtsei Pharmaceuticals, Inc.
CompletedNCT04479852
What is this study about?Researchers compared SP-624 and placebo to find out how the approaches affected depression symptoms in adults with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Sirtsei Pharmaceuticals, Inc.